Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2003European Journal of Gastroenterology & Hepatology

Crohn's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

KFKlaus FellermannGoethe University FrankfurtJWJan WehkampJanssen (United States)KHKlaus HerrlingerAsklepios Kliniken Hamburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fellermann et al. (2003) studied this question.

synapsesocial.com/papers/6a7162f5ac440176ef2a10achttps://doi.org/10.1097/00042737-200306000-00008
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease2002 · 201 citations
  2. 2Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).1996 · 1,027 citations
  3. 3Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease1995 · 295 citations
  4. 4Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species1987 · 239 citations
  5. 5Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues.1992 · 186 citations